Peniel M. Gumedzoe

Array ( [id] => 4171756 [patent_doc_number] => 06140359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Injectable composition' [patent_app_type] => 1 [patent_app_number] => 9/356158 [patent_app_country] => US [patent_app_date] => 1999-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1073 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140359.pdf [firstpage_image] =>[orig_patent_app_number] => 356158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239265 [patent_doc_number] => 06090811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Anti-neurogenic inflammatory compounds and compositions and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 9/356282 [patent_app_country] => US [patent_app_date] => 1999-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9958 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090811.pdf [firstpage_image] =>[orig_patent_app_number] => 356282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156573 [patent_doc_number] => 06114303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Hemoglobin therapy in hemodialysis' [patent_app_type] => 1 [patent_app_number] => 9/304173 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 2041 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114303.pdf [firstpage_image] =>[orig_patent_app_number] => 304173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182675 [patent_doc_number] => 06093417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Composition to treat ear disorders' [patent_app_type] => 1 [patent_app_number] => 9/228119 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5017 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093417.pdf [firstpage_image] =>[orig_patent_app_number] => 228119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086040 [patent_doc_number] => 06162827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Treatment of negative and cognitive symptoms of schizophrenia with D-serine' [patent_app_type] => 1 [patent_app_number] => 9/212273 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 5399 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162827.pdf [firstpage_image] =>[orig_patent_app_number] => 212273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4206248 [patent_doc_number] => 06077843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters' [patent_app_type] => 1 [patent_app_number] => 9/180659 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3739 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077843.pdf [firstpage_image] =>[orig_patent_app_number] => 180659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209684 [patent_doc_number] => 06110477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use' [patent_app_type] => 1 [patent_app_number] => 9/183034 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4261 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110477.pdf [firstpage_image] =>[orig_patent_app_number] => 183034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171953 [patent_doc_number] => 06140373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Propofol composition' [patent_app_type] => 1 [patent_app_number] => 9/178347 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2016 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140373.pdf [firstpage_image] =>[orig_patent_app_number] => 178347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997823 [patent_doc_number] => 05922735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => '4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators' [patent_app_type] => 1 [patent_app_number] => 9/166273 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922735.pdf [firstpage_image] =>[orig_patent_app_number] => 166273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032464 [patent_doc_number] => 05994384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use' [patent_app_type] => 1 [patent_app_number] => 9/043107 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2480 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994384.pdf [firstpage_image] =>[orig_patent_app_number] => 043107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4193118 [patent_doc_number] => 06043251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyr idine for preparing drugs for treating amyotrophic lateral sclerosis' [patent_app_type] => 1 [patent_app_number] => 9/051740 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2207 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043251.pdf [firstpage_image] =>[orig_patent_app_number] => 051740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938693 [patent_doc_number] => 05972999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Pharmaceutical compositions and methods for improving wrinkles and other skin conditions' [patent_app_type] => 1 [patent_app_number] => 9/146554 [patent_app_country] => US [patent_app_date] => 1998-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7586 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972999.pdf [firstpage_image] =>[orig_patent_app_number] => 146554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4110070 [patent_doc_number] => 06057368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Treatment of addiction and addiction-related behavior' [patent_app_type] => 1 [patent_app_number] => 9/129253 [patent_app_country] => US [patent_app_date] => 1998-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9948 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057368.pdf [firstpage_image] =>[orig_patent_app_number] => 129253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947015 [patent_doc_number] => 05977157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Methods for inhibiting endometriosis' [patent_app_type] => 1 [patent_app_number] => 9/107699 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5795 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977157.pdf [firstpage_image] =>[orig_patent_app_number] => 107699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926659 [patent_doc_number] => 05952364 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Methods for inhibiting smooth muscle cell proliferation' [patent_app_type] => 1 [patent_app_number] => 9/109280 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5793 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952364.pdf [firstpage_image] =>[orig_patent_app_number] => 109280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4224048 [patent_doc_number] => 06011057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Methods for inhibiting uterine fibroid disease' [patent_app_type] => 1 [patent_app_number] => 9/109298 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5793 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011057.pdf [firstpage_image] =>[orig_patent_app_number] => 109298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086859 [patent_doc_number] => 06025381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease' [patent_app_type] => 1 [patent_app_number] => 9/109297 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5793 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025381.pdf [firstpage_image] =>[orig_patent_app_number] => 109297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010921 [patent_doc_number] => 05962497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease' [patent_app_type] => 1 [patent_app_number] => 9/107852 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5792 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962497.pdf [firstpage_image] =>[orig_patent_app_number] => 107852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104224 [patent_doc_number] => 06100299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/093474 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3314 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100299.pdf [firstpage_image] =>[orig_patent_app_number] => 093474 [rel_patent_id] =>[rel_patent_doc_number] =>)